癌症干细胞：一个动态靶点。
Cancer Stem Cells: A Moving Target.
作者信息
Francipane Maria Giovanna, Chandler Julie, Lagasse Eric
机构信息
McGowan Institute for Regenerative Medicine, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA ; RiMed Foundation, 90133 Palermo, Italy.
出版信息
Curr Pathobiol Rep. 2013 Jun 1;1(2):111-118. doi: 10.1007/s40139-013-0010-2.
Abstract
Even though the number of anti-cancer drugs entering clinical trials and approved by the FDA has increased in recent years, many cancer patients still experience poor survival outcome. The main explanation for such a dismal prognosis is that current therapies might leave behind a population of cancer cells with the capacity for long-term self-renewal, so-called cancer stem cells (CSCs), from which most tumors are believed to be derived and fueled. CSCs might favor local and distant recurrence even many years after initial treatment, thus representing a potential target for therapies aimed at improving clinical outcome. In this review, we will address the CSC hypothesis with a particular emphasis on its current paradigms and debates, and discuss several mechanisms of CSC resistance to conventional therapies.
摘要
尽管近年来进入临床试验并获得美国食品药品监督管理局（FDA）批准的抗癌药物数量有所增加，但许多癌症患者的生存结局仍然不佳。对于如此糟糕的预后，主要解释是当前的治疗方法可能会留下一群具有长期自我更新能力的癌细胞，即所谓的癌症干细胞（CSCs），大多数肿瘤被认为起源于此并由其驱动生长。即使在初始治疗多年后，癌症干细胞仍可能导致局部和远处复发，因此是旨在改善临床结局的治疗的潜在靶点。在本综述中，我们将探讨癌症干细胞假说，特别强调其当前的模式和争议，并讨论癌症干细胞对传统疗法耐药的几种机制。
相似文献
1
Cancer Stem Cells: A Moving Target.癌症干细胞：一个动态靶点。
Curr Pathobiol Rep. 2013 Jun 1;1(2):111-118. doi: 10.1007/s40139-013-0010-2.
2
Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.癌症干细胞不会浪费时间进行清理——低蛋白酶体活性是癌症干细胞功能的一个标志物。
Ann Transl Med. 2016 Dec;4(24):519. doi: 10.21037/atm.2016.11.81.
3
Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.透明质酸及其CD44受体在癌症干细胞干性和存活中的关键作用
Front Oncol. 2015 Aug 10;5:180. doi: 10.3389/fonc.2015.00180. eCollection 2015.
4
miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.微小RNA-148a通过抑制INO80的表达来抑制甲状腺癌干细胞的自我更新。
Oncol Rep. 2016 Dec;36(6):3387-3396. doi: 10.3892/or.2016.5203. Epub 2016 Oct 25.
5
In vitro models of cancer stem cells and clinical applications.癌症干细胞的体外模型及临床应用
BMC Cancer. 2016 Sep 30;16(Suppl 2):738. doi: 10.1186/s12885-016-2774-3.
6
The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.前列腺癌干细胞的演变态势：治疗意义与未来挑战
Asian J Urol. 2016 Oct;3(4):203-210. doi: 10.1016/j.ajur.2016.09.006. Epub 2016 Sep 20.
7
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.癌症干细胞免疫学和免疫疗法：利用免疫系统对抗癌症的根源。
Prog Mol Biol Transl Sci. 2019;164:119-188. doi: 10.1016/bs.pmbts.2019.03.008. Epub 2019 Apr 11.
8
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.癌症干细胞异质性：起源及针对癌症干细胞的新观点
BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222.
9
Nanomedicine-mediated cancer stem cell therapy.纳米医学介导的癌症干细胞治疗。
Biomaterials. 2016 Jan;74:1-18. doi: 10.1016/j.biomaterials.2015.09.037. Epub 2015 Sep 28.
10
Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage.穿透癌症干细胞防线以应对辐射抗性的策略。
Recent Pat Anticancer Drug Discov. 2018;13(1):18-39. doi: 10.2174/1574892812666171003150410.
引用本文的文献
1
Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure.5-氟尿嘧啶耐药人结直肠癌细胞株的建立及鉴定：选择压力下的肿瘤动力学。
Int J Mol Sci. 2019 Apr 12;20(8):1817. doi: 10.3390/ijms20081817.
2
G-protein-signaling modulator 2 expression and role in a CD133 pancreatic cancer stem cell subset.G蛋白信号调节剂2在CD133阳性胰腺癌干细胞亚群中的表达及作用
Onco Targets Ther. 2019 Jan 23;12:785-794. doi: 10.2147/OTT.S187670. eCollection 2019.
3
Towards Organs on Demand: Breakthroughs and Challenges in Models of Organogenesis.迈向按需器官：器官发生模型的突破与挑战
Curr Pathobiol Rep. 2016 Sep;4(3):77-85. doi: 10.1007/s40139-016-0111-9. Epub 2016 Jul 2.
4
All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.全反式维甲酸抑制CD133阳性甲状腺癌干细胞的恶性特征并诱导其凋亡。
PLoS One. 2017 Aug 17;12(8):e0182835. doi: 10.1371/journal.pone.0182835. eCollection 2017.
5
RalA is overactivated in medulloblastoma.RalA在髓母细胞瘤中过度激活。
J Neurooncol. 2016 Oct;130(1):99-110. doi: 10.1007/s11060-016-2236-4. Epub 2016 Aug 26.
6
A simple, low-cost staining method for rapid-throughput analysis of tumor spheroids.一种用于肿瘤球体快速通量分析的简单、低成本染色方法。
Biotechniques. 2016 Jan 1;60(1):43-6. doi: 10.2144/000114372. eCollection 2016 Jan.
7
Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.mTOR抑制剂靶向癌症干细胞的治疗潜力。
Br J Clin Pharmacol. 2016 Nov;82(5):1180-1188. doi: 10.1111/bcp.12844. Epub 2015 Dec 26.
8
Distinct human stem cell populations in small and large intestine.小肠和大肠中不同的人类干细胞群体。
PLoS One. 2015 Mar 9;10(3):e0118792. doi: 10.1371/journal.pone.0118792. eCollection 2015.
9
p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.p53上调的凋亡调节因子通过增强凋亡使耐药的U251胶质母细胞瘤干细胞对替莫唑胺敏感。
Mol Med Rep. 2015 Jun;11(6):4165-73. doi: 10.3892/mmr.2015.3255. Epub 2015 Jan 26.
10
Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.核酸适配体引导的癌症治疗与诊断：新一代癌症医学
Theranostics. 2015 Jan 1;5(1):23-42. doi: 10.7150/thno.10202. eCollection 2015.
本文引用的文献
1
Redox regulation in stem-like cancer cells by CD44 variant isoforms.CD44 变体亚型在干细胞样癌细胞中的氧化还原调控。
Oncogene. 2013 Oct 31;32(44):5191-8. doi: 10.1038/onc.2012.638. Epub 2013 Jan 21.
2
Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.Lgr5 是结直肠癌干细胞的一个潜在标志物，与患者的生存相关。
World J Surg Oncol. 2012 Nov 15;10:244. doi: 10.1186/1477-7819-10-244.
3
Erlotinib antagonizes ABC transporters in acute myeloid leukemia.厄洛替尼拮抗急性髓系白血病中的 ABC 转运蛋白。
Cell Cycle. 2012 Nov 1;11(21):4079-92. doi: 10.4161/cc.22382. Epub 2012 Oct 24.
4
Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.致癌基因诱导神经元和星形胶质细胞去分化可诱发小鼠脑胶质瘤。
Science. 2012 Nov 23;338(6110):1080-4. doi: 10.1126/science.1226929. Epub 2012 Oct 18.
5
The role of DNA repair in the pluripotency and differentiation of human stem cells.DNA 修复在人类干细胞的多能性和分化中的作用。
Mutat Res. 2013 Jan-Mar;752(1):25-35. doi: 10.1016/j.mrrev.2012.09.001. Epub 2012 Sep 23.
6
Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.PTEN 和 mTORC2 调控造血干细胞自我更新和白血病抑制的时空调控变化。
Cell Stem Cell. 2012 Sep 7;11(3):415-28. doi: 10.1016/j.stem.2012.05.026.
7
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.谱系追踪揭示了小鼠肠腺瘤中 Lgr5+干细胞的活性。
Science. 2012 Aug 10;337(6095):730-5. doi: 10.1126/science.1224676. Epub 2012 Aug 1.
8
Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.低分子量肝素通过诱导蛋白酶体介导的 ABCG2 蛋白降解来消除肺癌顺铂耐药性。
PLoS One. 2012;7(7):e41035. doi: 10.1371/journal.pone.0041035. Epub 2012 Jul 23.
9
Oxidatively damaged DNA and its repair in colon carcinogenesis.氧化损伤的 DNA 及其在结肠癌发生中的修复。
Mutat Res. 2012 Aug 1;736(1-2):82-92. doi: 10.1016/j.mrfmmm.2012.04.003. Epub 2012 Apr 25.
10
Regulation of intestinal cancer stem cells.肠道肿瘤干细胞的调控。
Cancer Lett. 2013 Sep 10;338(1):120-6. doi: 10.1016/j.canlet.2012.04.016. Epub 2012 Apr 27.
Zotero 插件